SOFIA GAMIDOVA: Open Payments
NPI 1326481276 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$416 in 16 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $416
Food & beverage: $416
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 2 | $125 |
| Averitas Pharma Inc. | 2 | $45 |
| SI-BONE, INC. | 1 | $33 |
| ABBVIE INC. | 2 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Tonix Medicines, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
Products named: REZDIFFRA, QUTENZA, QULIPTA, INGREZZA, KESIMPTA, Kerendia, TONMYA, NURTEC ODT.
Industry payments across NY — which companies pay providers there.
